期刊文献+

口服与灌肠联合口服给药治疗溃疡性结肠炎临床对比研究 被引量:4

Clinical study on efficacy of oral administration of drugs and Chinese traditional medicine enema in treatment of 59 patients with ulcerative colitis
下载PDF
导出
摘要 目的研究口服与灌肠联合口服给药治疗溃疡性结肠炎的临床效果,为临床该类疾病的治疗提供依据。方法将59例溃疡性结肠炎患者随机分为口服给药组(对照组,口服美沙拉嗪)和口服联合灌肠给药组(治疗组,口服美沙拉嗪+中药灌肠),比较两组患者的临床有效率,治疗前后的临床症状和肠黏膜的病变程度,并比较两组患者的不良反应。结果治疗组患者的临床有效率可达93.8%,高于对照组,差异有统计学意义(P<0.05);治疗组患者临床症状积分低于对照组,差异有统计学意义(P<0.05);治疗组患者的肠黏膜病变程度得到明显改善,差异有统计学意义(P<0.05);两组不良反应发生率相似,差异无统计学意义(P>0.05)。结论口服联合灌肠给药改善溃疡性结肠炎患者临床症状更明显,患者肠黏膜病变程度恢复更彻底,明显好于单独的口服给药,并且用药安全,无额外不良反应发生。 Objective To study the clinical efficacy of oral drugs combined with Chinese traditional medicine enema in treatment of ulcer- ative colitis and to provide the basis for treatment of this disease. Methods A total of 59 patients with ulcerative colitis during October 2007 to September 2011 were randomly divided into two groups, oral drug treatment group ( control group) and oral drug combined with enema group ( trial group), patients in control group were treated with oral drugs and patients in trial group were given with oral drugs combined with Chinese medi- cine enema. Their clinical effects had been observed and compared. Results The total effective rate of trial group was 93.8% , and it was higher than that of control group, and their difference was statistically significant ( P 〈 0.05 ). The grade of scores in elinical symptoms was the lowest for trial group, it was statistically significant compared with that of control group( P 〈0.05) ; and the changes in lesions of intestinal mueosa in pa- tients of trial group were less than those of control group, and their difference was statistically significant ( P 〈 0.05 ) ; and the occurrence of side effects in these two groups was equivalent, and their difference was not significant ( P 〉 0.05 ). Conclusion The effieacy of oral drugs combined with Chinese traditional medicine enema is more satisfactory in treatment of ulcerative colitis, and it is better than administration of oral drugs a- lone, there was no more side effects occurred.
出处 《临床和实验医学杂志》 2013年第24期1982-1984,共3页 Journal of Clinical and Experimental Medicine
关键词 溃疡性结肠炎 口服给药 灌肠给药 对比研究 Ulcerative colitis Oral administration Enema Comparative study
  • 相关文献

参考文献10

二级参考文献24

  • 1吴曦,刘新光,田雨,李俊霞.炎症性肠病患者的肠外表现(附201例临床分析)[J].中国实用内科杂志,2006,26(2):190-193. 被引量:16
  • 2李东淑.中医药治疗溃疡性结肠炎的临床研究进展[J].中医药信息,2006,23(5):22-24. 被引量:2
  • 3Bibiloni R, Fedorak RN, Tannock GW, et al. VSL#3 probioticmixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol,2005,100 : 1539 -1546.
  • 4Furrie E, Macfarlane S, Kennedy A, et al. Synbiotic therapy (Bifidobacterium longum/Synergy 1 ) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut ,2005,54:242-249.
  • 5Kornbluth A, Sachar DB, Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults (update) : American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol,2004, 99:1371-1385.
  • 6Pullan RD, Rhodes J, Ganesh S,et al. Transdermal nicotine for active ulcerative colitis. N Engl J Med,1994,330:811-815.
  • 7Fedorak RN, Madsen KL. Probiotics and the management of inflammatory bowel disease. Inflamm Bowel Dis, 2004, 10:286- 299.
  • 8Guarner C, Runyon BA, Young S,et al. Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J Hepatol, 1997,26 : 1372-1378.
  • 9Fiocchi C. Microbial factors in the pathogenesis of IBD. Bioscience Microflora,2003 ,22 :5-14.
  • 10Marteau P, Lepage P, Mangin I, et al. gut flora and inflammatory bowel disease. Aliment Phannacol Ther,2004,20( Suppl 4) : 18- 23.

共引文献1281

同被引文献50

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部